Skip to main content
Top
Published in: International Orthopaedics 3/2024

23-09-2023 | Tranexamic Acid | Original Paper

Intra-articular injection of tranexamic acid in patients with haemophilia arthritis: retrospective controlled study in total knee arthroplasty

Authors: Si-cheng Xiang, Shao-ning Shen, Rui Wang, Zheng-ming Wang, Zhao-kai Jin, Hai Su, Pei-jian Tong, Shuai-jie Lv

Published in: International Orthopaedics | Issue 3/2024

Login to get access

Abstract

Purpose

Total knee arthroplasty is the main method for the treatment of advanced haemophilic knee arthritis. Due to the particularity of hemophilia, the blood management plan is the focus of the perioperative period for haemophilia patients. This study aimed to investigate the clinical effect and safety of intra-articular injection of tranexamic acid in patients with haemophilia.

Methods

This is a retrospective study. According to whether tranexamic acid is used or not, patients are divided into tranexamic acid group (n=30) and non-tranexamic acid group (n=29). Total blood loss, intraoperative blood loss, complete blood count, total amount of coagulation factor VIII (FVIII) usage, coagulation biomarkers, inflammatory biomarkers, knee range of motion, knee joint function, pain status, complication rate, and patient satisfaction were assessed and compared at a mean follow-up of 16 months.

Results

Injecting tranexamic acid into the knee joint cavity can effectively reduce the hidden blood loss and total blood loss (P<0.001), and reduce the patient’s early postoperative inflammation biomarkers, pain status, and limb swelling. Therefore, the patient can obtain a better range of motion following total knee arthroplasty. In the long run, in terms of joint function and surgical satisfaction, there are no statistically significant differences. In addition, there are no statistically significant differences between the two groups of patients in terms of the total amount of FVIII usage, length of stay, and hospitalization expenses.

Conclusion

In patients with haemophilia, intra-articular injection of tranexamic acid during total knee arthroplasty can effectively reduce postoperative blood loss, early postoperative inflammation levels, pain and limb swelling, and enable patients to receive higher-quality rehabilitation exercises to get better joint function. Previous studies on TKA in haemophilic patients have already demonstrated the efficacy of intra-articular injections of TXA in reducing postoperative blood loss. Our study confirms this efficacy.
Literature
8.
go back to reference Ye S et al (2023) Comparative study of carbazochrome sodium sulfonate and tranexamic acid in reducing blood loss and inflammatory response following direct anterior total hip arthroplasty: a prospective randomized controlled trial. Int Orthop 20. https://doi.org/10.1007/s00264-023-05853-3 Ye S et al (2023) Comparative study of carbazochrome sodium sulfonate and tranexamic acid in reducing blood loss and inflammatory response following direct anterior total hip arthroplasty: a prospective randomized controlled trial. Int Orthop 20. https://​doi.​org/​10.​1007/​s00264-023-05853-3
Metadata
Title
Intra-articular injection of tranexamic acid in patients with haemophilia arthritis: retrospective controlled study in total knee arthroplasty
Authors
Si-cheng Xiang
Shao-ning Shen
Rui Wang
Zheng-ming Wang
Zhao-kai Jin
Hai Su
Pei-jian Tong
Shuai-jie Lv
Publication date
23-09-2023
Publisher
Springer Berlin Heidelberg
Published in
International Orthopaedics / Issue 3/2024
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-023-05983-8

Other articles of this Issue 3/2024

International Orthopaedics 3/2024 Go to the issue